Kura Oncology Inc • KURA

Capital at risk.

About Kura Oncology Inc
Ticker
info
KURA
Trading on
info
NASDAQ
ISIN
info
-
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Troy Edward Wilson J.D., Ph.D.
Headquarters
info
4930 Directors Place, San Diego, CA, United States, 92121
Employees
info
260
Website
info
https://kuraoncology.com
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Metrics
BasicAdvanced
Market cap
info
$902M
P/E ratio
info
-
EPS
info
-$3.37
Dividend Yield
info
0.00%
Beta
info
0.47
Forward P/E ratio
info
0
EBIDTA
info
$-317M
Ex dividend date
info
-
Price & volume
Market cap
info
$902M
Average daily volume
info
1.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
11.68
Price to book
info
20.26
Earnings
EPS
info
-$3.37
EPS estimate (current quarter)
info
-$0.88
EPS estimate (next quarter)
info
-$0.89
EBITDA
info
$-317M
Revenues (TTM)
info
$77.2M
Revenues per share (TTM)
info
$0.88
Technicals
Beta
info
0.47
52-week High
info
$13.90
52-week Low
info
$7.36
50-day moving average
info
$11.30
200-day moving average
info
$9.81
Short ratio
info
7.92
Short %
info
16.64%
Management effectiveness
ROE (TTM)
info
-167.71%
ROA (TTM)
info
-31.30%
Profit margin
info
0.00%
Gross profit margin
info
$-183M
Operating margin
info
-349.77%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
36.50%
Share stats
Outstanding Shares
info
89M
Float
info
70.5M
Insiders %
info
1.40%
Institutions %
info
100.08%
Analyst Insights & forecasts
info

94% Buy

6% Hold

0% Sell

Based on information from 16 analysts.

Average price target

info
$31.85
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.85
-$0.68
-25.00%
Q3 • 25Missed
-$0.92
-$0.49
-87.76%
Q4 • 25Missed
-$0.83
-$0.90
8.35%
Q1 • 26Beat
-$0.77
-$0.89
13.48%
Q2 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$18.3M
$-73.3M
-401.49%
Q1 • 26
$20.9M
$-68.3M
-327.33%
Q2 • 26
14.28%
-6.83%
-18.47%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$653M
$545M
83.47%
Q1 • 26
$588M
$539M
91.76%
Q2 • 26
-9.92%
-0.97%
9.94%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-85.9M
$-24.1M
$0.1M
$-86M
Q1 • 26
$-62.5M
$92.9M
$1.5M
$-63.2M
Q2 • 26
-27.14%
-485.28%
2,072.46%
-26.49%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Kura Oncology Inc share?
Collapse

Kura Oncology Inc shares are currently traded for undefined per share.

How many shares does Kura Oncology Inc have?
Collapse

Kura Oncology Inc currently has 89M shares.

Does Kura Oncology Inc pay dividends?
Collapse

No, Kura Oncology Inc doesn't pay dividends.

What is Kura Oncology Inc 52 week high?
Collapse

Kura Oncology Inc 52 week high is $13.90.

What is Kura Oncology Inc 52 week low?
Collapse

Kura Oncology Inc 52 week low is $7.36.

What is the 200-day moving average of Kura Oncology Inc?
Collapse

Kura Oncology Inc 200-day moving average is $9.81.

Who is Kura Oncology Inc CEO?
Collapse

The CEO of Kura Oncology Inc is Dr. Troy Edward Wilson J.D., Ph.D..

How many employees Kura Oncology Inc has?
Collapse

Kura Oncology Inc has 260 employees.

What is the market cap of Kura Oncology Inc?
Collapse

The market cap of Kura Oncology Inc is $902M.

What is the P/E of Kura Oncology Inc?
Collapse

The current P/E of Kura Oncology Inc is null.

What is the EPS of Kura Oncology Inc?
Collapse

The EPS of Kura Oncology Inc is -$3.37.

What is the PEG Ratio of Kura Oncology Inc?
Collapse

The PEG Ratio of Kura Oncology Inc is 0.

What do analysts say about Kura Oncology Inc?
Collapse

According to the analysts Kura Oncology Inc is considered a buy.